GL1X · GenesisL1 explorer

MolNFT v1 · #66758 · protein

Crystal structure of S73-2 antibody in complex with antigen KDO(2.4) KDO(2.4)KDO

3HZY · S73-2 Fab (IGG1K) light chain: “Crystal structure of S73-2 antibody in complex with antigen KDO(2.4) KDO(2.4)KDO”. X-ray diffraction, 4 ligands (KDA, KDO, ZN), 5 pockets (best druggability 0.61). MolNFT v1 #66758 on GenesisL1: 3D…

PDB
3HZY
Type
protein
Length
434 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
S73-2 Fab (IGG1K) light chain; S73-2 Fab (IGG1K) heavy chain
Ligands
KDA, KDO, ZN, MG
Pockets
5 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AS73-2 Fab (IGG1K) light chainprotein2156% helix, 53% strand—
BS73-2 Fab (IGG1K) heavy chainprotein2197% helix, 49% strand—

Ligands and binding sites

  • KDA · prop-2-en-1-yl 3-deoxy-alpha-D-manno-oct-2-ulopyranosidonic acid · ligand · chains A
  • KDO · 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid · sugar · 2 copies · chains B, A
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15280.610.7553empty
2760.520.8523empty
3620.350.7813empty
4720.290.7320empty
5500.230.7216KDO

Interfaces

1 interface between chains.

  • A–B · 1748 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3HZY · Crystal structure of S73-2 antibody in complex with antigen Kdo(2.4)Kdo(2.4)Kdo · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.